• Home/
  • Erratum for CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

Erratum for CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

International Journal of Cancer 2022
Hong SP, et al.

Hong SP, Wen J, Bang S, Park S, Song SY.

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

Top

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.